PMV PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.75 USD | +2.34% |
|
+8.70% | -43.55% |
Chart calendar PMV Pharmaceuticals, Inc.
1e9c36b6.hwjtnH44DBheH9RSpKXyxWh3HgYIiNgDg8VY4RhZV7o.7H7A1wtCeEsyarw71MTHrgQcZmhEwKou4vFor2wQCMDYcKuxDgF9SQls4A~c7577aacdd2d71a9047bac4887d6c5f5
Upcoming events on PMV Pharmaceuticals, Inc.
Past events on PMV Pharmaceuticals, Inc.
| 2024-03-04 02:50 pm | TD Cowen Health Care Conference |
| 2024-02-29 04:01 pm | Q4 2023 Earnings Release |
| 2024-01-18 03:00 pm | B. Riley Securities Oncology Conference |
| 2023-11-09 08:00 am | Q3 2023 Earnings Release |
| 2023-10-14 10:00 am | AACR-NCI-EORTC International Conference |
| 2023-10-13 06:00 pm | AACR-NCI-EORTC International Conference |
| 2023-10-12 04:00 pm | Investor Meeting - Key Opinion Leader |
| 2023-10-12 12:30 pm | AACR-NCI-EORTC International Conference - Abstract No LB_A25 |
| 2023-08-09 08:00 am | Q2 2023 Earnings Release |
| 2023-06-13 11:00 am | Goldman Sachs Global Healthcare Conference |
| 2023-06-08 10:00 am | Annual General Meeting |
| 2023-05-10 08:00 am | Q1 2023 Earnings Release |
| 2023-03-13 08:00 am | Oppenheimer Healthcare Conference |
| 2023-03-08 09:10 am | Cowen Health Care Conference |
| 2023-03-01 08:00 am | Q4 2022 Earnings Release |
| 2022-11-29 03:05 pm | Evercore ISI HealthCONx Conference |
| 2022-11-08 08:00 am | Q3 2022 Earnings Release |
| 2022-08-09 08:00 am | Interim 2022 Earnings Release |
| 2022-06-14 04:20 pm | Goldman Sachs Global Healthcare Conference |
| 2022-06-07 07:30 pm | PC14586 Phase 1 Trial Results Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,06 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -34,6 -34,8 0.47% | -58,0 -53,8 -7.87% | -76,7 -76,4 -0.42% | -78,9 -83,1 5.05% | -107 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -34,9 -34,7 -0.74% | -58,3 -55,8 -4.38% | -77,0 -76,6 -0.53% | -80,1 -82,0 2.22% | -83,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -34,4 -31,5 -9.48% | -57,8 -56,2 -2.9% | -73,3 -74,3 1.3% | -69,0 -71,9 4.11% | -73,0 |
|
Net income Million USD | Released Forecast Spread | -25,4 | -34,4 -32,1 -7.33% | -57,8 -55,8 -3.66% | -73,3 -74,3 1.34% | -69,0 -71,9 4.09% | -73,0 |
|
EPS USD | Released Forecast Spread | -8,37 | -2,40 -1,16 -106.9% | -1,28 -1,23 -3.9% | -1,61 -1,64 1.73% | -1,44 -1,51 4.64% | -1,44 |
| Announcement Date | 26/06/20 | 03/03/21 | 01/03/22 | 01/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -18,4 -14,8 -24.13% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -18,5 -16,0 -15.33% | -18,6 -18,6 -0.01% | -17,9 -19,1 6.29% | -19,4 -19,5 0.86% | -21,2 -20,8 -1.98% | -21,5 -21,6 0.58% | -20,1 -22,8 11.64% | -19,6 -21,4 8.36% | -18,9 -20,7 8.79% | -19,9 | -20,7 | -21,6 | -21,4 | -25,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,4 -16,7 -9.91% | -18,4 -19,7 6.6% | -17,3 -19,9 12.91% | -18,2 -19,4 5.91% | -19,3 -20,2 4.32% | -19,1 -21,8 12.07% | -17,4 -22,2 21.56% | -16,6 -20,4 18.37% | -15,8 -18,7 15.81% | -17,1 | -18,1 | -18,6 | -19,3 | -25,0 |
|
Net income Million USD | Released Forecast Spread | -18,4 -16,3 -12.56% | -18,4 -19,1 3.7% | -17,3 -19,3 10.38% | -18,2 -19,2 5.11% | -19,3 -20,1 3.62% | -19,1 -21,1 9.29% | -17,4 -21,6 19.41% | -16,6 -20,4 18.37% | -15,8 -18,7 15.81% | -17,1 | -18,1 | -18,6 | -19,3 | -25,0 |
|
EPS USD | Released Forecast Spread | -0,40 -0,36 -12.36% | -0,41 -0,42 2.84% | -0,38 -0,42 9.09% | -0,40 -0,42 5.66% | -0,43 -0,44 1.83% | -0,42 -0,46 8.3% | -0,38 -0,47 19.83% | -0,34 -0,44 23.16% | -0,31 -0,38 17.33% | -0,34 | -0,35 | -0,36 | -0,38 | -0,49 |
| Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 09/11/23 | 29/02/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for PMV Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PMVP Stock
- Calendar PMV Pharmaceuticals, Inc.
